Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy

Overview of attention for article published in Progress in Cardiovascular Diseases, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user

wikipedia: 3 Wikipedia pages

Readers on

mendeley: 91 Mendeley

So far, Altmetric has seen 1 X post from an account with 13,470 followers.

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy @PCSK9Forum http://t.co/Agu5oNElAh

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.